NO963805L - Cefalosporinderivater - Google Patents

Cefalosporinderivater

Info

Publication number
NO963805L
NO963805L NO963805A NO963805A NO963805L NO 963805 L NO963805 L NO 963805L NO 963805 A NO963805 A NO 963805A NO 963805 A NO963805 A NO 963805A NO 963805 L NO963805 L NO 963805L
Authority
NO
Norway
Prior art keywords
fluoro
lower alkyl
hydroxyphenyl
carboxy
substituted
Prior art date
Application number
NO963805A
Other languages
English (en)
Norwegian (no)
Other versions
NO963805D0 (no
Inventor
Paul Hebeisen
Ingrid Heinze-Krauss
Hans Richter
Valeri Runtz
Henri Stalder
Urs Weiss
George Petros Yiannikouros
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO963805D0 publication Critical patent/NO963805D0/no
Publication of NO963805L publication Critical patent/NO963805L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO963805A 1995-09-12 1996-09-11 Cefalosporinderivater NO963805L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95114304 1995-09-12
EP95114303 1995-09-12

Publications (2)

Publication Number Publication Date
NO963805D0 NO963805D0 (no) 1996-09-11
NO963805L true NO963805L (no) 1997-03-13

Family

ID=26138799

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963805A NO963805L (no) 1995-09-12 1996-09-11 Cefalosporinderivater

Country Status (15)

Country Link
US (1) US5804577A (fr)
JP (1) JPH09132578A (fr)
KR (1) KR100209839B1 (fr)
CN (1) CN1060778C (fr)
AU (1) AU709077B2 (fr)
CA (1) CA2184971A1 (fr)
CO (1) CO4750667A1 (fr)
CZ (1) CZ251896A3 (fr)
HU (1) HUP9602433A3 (fr)
IL (1) IL119215A0 (fr)
MA (1) MA23970A1 (fr)
NO (1) NO963805L (fr)
PL (1) PL316032A1 (fr)
SG (1) SG52841A1 (fr)
TR (1) TR199600715A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090013A1 (fr) * 1998-06-22 2001-04-11 F. Hoffmann-La Roche Ag Deriues de cephalosporine de propenyle
DE69938094T2 (de) * 1998-11-30 2009-02-05 Matsushita Electric Industries Co. Ltd., Kadoma Paketwiederübertragungskontrolle mit Prioritätsinformationen
MXPA03001310A (es) * 2000-08-14 2003-06-30 Basilea Pharmaceutica Ag Preparacion de sales de fosfonio sustituidas con 3-pirrolidin-lactama n-protegida.
KR101128065B1 (ko) * 2004-05-26 2012-04-12 에자이 알앤드디 매니지먼트 가부시키가이샤 신나미드 화합물
US7923563B2 (en) 2004-10-26 2011-04-12 Eisai R&D Management Co., Ltd. Amorphous object of cinnamide compound
AU2006316005A1 (en) * 2005-11-18 2007-05-24 Eisai R & D Management Co., Ltd. Process for production of cinnamamide derivative
JPWO2007058304A1 (ja) * 2005-11-18 2009-05-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 シンナミド化合物の塩またはそれらの溶媒和物
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
KR20090016591A (ko) * 2006-05-19 2009-02-16 에자이 알앤드디 매니지먼트 가부시키가이샤 헤테로사이클 타입의 신나미드 유도체
AU2007252643A1 (en) * 2006-05-19 2007-11-29 Eisai R & D Management Co., Ltd. Urea type cinnamide derivative
US20080207900A1 (en) * 2007-02-28 2008-08-28 Teiji Kimura Two cyclic oxomorphorin derivatives
AU2008250119A1 (en) * 2007-05-16 2008-11-20 Eisai R & D Management Co., Ltd. One-pot production process for cinnamide derivative
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
CA2694401C (fr) * 2007-08-31 2012-12-04 Eisai R&D Management Co., Ltd. Compose polycyclique
CA2712095A1 (fr) * 2008-01-28 2009-08-06 Eisai R&D Management Co., Ltd. Composes cristallins de cinnamide ou sels de ceux-ci

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
PT620225E (pt) * 1993-04-16 2003-03-31 Basilea Pharmaceutica Ag Derivados de cefalosporina
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics

Also Published As

Publication number Publication date
TR199600715A2 (tr) 1997-03-21
CZ251896A3 (en) 1997-04-16
US5804577A (en) 1998-09-08
IL119215A0 (en) 1996-12-05
HUP9602433A2 (en) 1997-05-28
AU6550696A (en) 1997-03-20
JPH09132578A (ja) 1997-05-20
CO4750667A1 (es) 1999-03-31
KR100209839B1 (ko) 1999-07-15
HU9602433D0 (en) 1996-10-28
NO963805D0 (no) 1996-09-11
HUP9602433A3 (en) 2001-04-28
CN1060778C (zh) 2001-01-17
KR970015593A (ko) 1997-04-28
SG52841A1 (en) 1998-09-28
MX9604017A (es) 1997-07-31
CN1150950A (zh) 1997-06-04
PL316032A1 (en) 1997-03-17
AU709077B2 (en) 1999-08-19
CA2184971A1 (fr) 1997-03-13
MA23970A1 (fr) 1997-04-01

Similar Documents

Publication Publication Date Title
NO963805L (no) Cefalosporinderivater
NO962386L (no) Heterocykliske ring-kondenserte pyrimidin-derivater
HU9301155D0 (en) Methods for producing steroide derivatives and for their application in medical treatment
IN2015DN01133A (fr)
NO20013369L (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
CA2296031A1 (fr) Nouveaux composes spiroazabicycliques heterocycliques
CA2139109A1 (fr) Agents antiangineux a base de purinone
NO20072399L (no) Nye pyrrolo[3,2-d]pyrimidin-4-o-derivater og deres anvendelse i terapi
NO920417L (no) Aminosyrederivater
TNSN05320A1 (en) Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors
WO2004024728A3 (fr) Composes de pyrazolo[3,4-b]pyridine et leur utilisation en tant qu'inhibiteurs de phosphodiesterase
EP1199306A4 (fr) Derives de biaryluree
AU3821889A (en) 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
CA2208792A1 (fr) Derives indazoles substitues
NO994900L (no) Forbindelser
IE890177L (en) Piperidinyl derivatives
HU9401298D0 (en) Substituted pyrrol derivatives
AU2001292350A1 (en) Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
PT1303514E (pt) Processo para preparacao de azacicloalcanoilaminotiazoles
AU7624394A (en) Optically active imidazolidinone derivative and process for producing the same
NO993372L (no) Substituerte 4-(6-fluor-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridin for behandling av CNS-forstyrrelser
AU538882B2 (en) 2,3-dihydro-imidazo(1,2-g)pyridazine derivatives
CA2048959A1 (fr) Les 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines et leurs derives
WO2003099819A3 (fr) Derives d'oxophenyl-cyclohexyl-propanolamine, leur preparation et leur application en therapeutique
GR861207B (en) Process for preparing novel 1,3-oxathiane derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application